Summary of this article
Park Medi World IPO is set to close today, it has been subscribed 2.06 times overall, with NIIs leading demand at 4.55 times.
The grey market premium (GMP) dipped from Rs 14 to Rs 12 per share, suggesting listing gains of around 7.4 per cent.
The hospital chain aims to raise Rs 920 crore; shares are scheduled to list on the bourses on December 17.
Park Medi World IPO Subscription: The subscription window of Park Medi World’s initial public offering (IPO) is scheduled to close today, December 12. The hospital chain’s public issue saw weak demand on the final day of bidding.
Park Medi World IPO has been subscribed to more than 2 times so far. Additionally, the grey market premium (GMP) for the company’s shares has also dipped. Here’s a look at some of the key details related to the aerospace component maker’s public issue:
Park Medi World IPO Subscription On Day 3
On the third day of subscription, Park Medi World IPO was subscribed 2.06 times. Cumulatively, the issue received bids for 85.95 million shares compared to the 41.81 million shares offered for subscription.
On all three days of subscription, the non-institutional investor (NII) category led the demand for the hospital chain operator’s shares. NIIs booked their quota in the public issue 4.55 times as they bid for 40.73 million shares compared to the 8.96 million shares reserved for them.
Park Medi World IPO has been booked 1.97 times by retail individual investors (RIIs) so far. RIIs applied for 41.14 million shares against the 20.9 million shares set aside for retail investors.
Qualified institutional buyers (QIBs) booked their quota in the public issue, 34 per cent. QIBs applied for 4.07 million shares compared to the 11.94 million shares set aside for the category.
Park Medi World IPO GMP
Park Medi World IPO grey market premium (GMP) dipped on the final day of bidding from Rs 14 per share to Rs 12 per share as per several websites which monitor the demand for shares of unlisted companies. Park Medi World shares are expected to list with gains of 7.4 per cent at Rs 174 per share.
Park Medi World IPO Issue Size
Park Medi World seeks to raise Rs 920 crore from its public issue. The hospital chain operator’s issue size consists of a fresh issue of 47.5 million shares amounting to Rs 770 crore and an offer for sale of 9.3 million shares amounting to Rs 150 crore.
Park Medi World IPO Price Band
Park Medi World IPO price band was set at Rs 154 to Rs 162 per share. The minimum lot size for retail individual investors was fixed at 92 shares, which aggregates to an investment of Rs 14,904.
Park Medi World IPO: Subscription Dates and Listing Date
Park Medi World IPO subscription window opened on December 10 and closed on December 12. The basis of allotment for the Park Medi World IPO will be announced on December 15. Park Medi World will issue refunds for unsuccessful applicants on December 16. Park Medi World shares are scheduled to list on the bourses on December 17.
Park Medi World: Financials
Park Medi World’s total income for the September quarter of FY26 stood at Rs 823.39 crore. The hospital chain operator’s net profit and net worth for the September quarter were Rs 139.14 crore and Rs 1,153.05 crore, respectively.
In FY25, the hospital chain posted a total income of Rs 1425.97, increasing over 12 per cent from Rs 1263.08 crore in the preceding fiscal. The company’s net profit for FY25 stood at Rs 213.22 crore, increasing by over 40 per cent from Rs 152.01 crore in the preceding fiscal. The net worth of the company increased by more than 25 per cent to Rs 1021.86 crore in FY25 compared to Rs 815.98 crore in FY24.
Park Medi World IPO: Registrar
The registrar for Park Medi World IPO is Kfin Technologies, and the book-running lead manager for the issue is Nuvama Wealth Management.
Park Medi World: Promoters
The promoters of the company include Dr Ajit Gupta and Dr Ankit Gupta. The promoters held 95.55 per cent stake in the company prior to the issue. Post the issue, their shareholding will reduce to 82.89 per cent.
Park Medi World IPO: Objective
Park Medi World seeks to use the money raised via the public issue for repayment of its borrowings and the borrowings of its subsidiaries. The funds will also be used for the development of new hospitals and the expansion of existing hospitals under its subsidiary Park Medicity (NCR) and Blue Heavens. Additionally, the funds will also be used to procure medical equipment and undertake inorganic acquisitions and general corporate purposes.
About Park Medi World
Park Medi World operates a private hospital chain in India. The company’s hospitals have a total bed capacity of 3,000 beds as of March 31, 2025. It runs 14 multi-super speciality hospitals under the ‘Park’ brand. The hospitals offer services such as internal medicine, neurology, urology, gastroenterology, general surgery, orthopaedics, and oncology.
